Free Pharmacovigilance Course
Pharmacovigilance Essentials
Learn pharmacovigilance, ADR classification, causality assessment, case reporting, MedDRA coding, safety signals, and regulatory timelines. Join this Free Pharmacovigilance Course to build core drug safety skills.
About this course
The free online pharmacovigilance course equips you with the foundational skills to understand how drug safety is monitored, evaluated, and reported after medicines reach patients. You’ll learn the purpose of pharmacovigilance, the impact of events such as the thalidomide disaster, adverse drug reaction classification, seriousness versus severity, expected reactions, causality assessment, safety data sources, and the requirements for a valid case report. The course also covers safety narrative writing, MedDRA coding basics, ICH guidelines, regulatory reporting timelines, and quality practices used in global drug safety. You’ll also learn how pharmacovigilance operates in India, how safety signals are identified and interpreted, and how findings can lead to label changes and other risk management actions. By the end of this free pharmacovigilance training course, you’ll be able to assess adverse drug reactions, evaluate case validity and causality, understand core regulatory requirements, interpret safety signals, and build a strong foundation for entry-level pharmacovigilance, drug safety, and regulatory support roles.
Course outline
Introduction to Pharmacovigilance
In this module, you'll learn what pharmacovigilance means, how disasters like thalidomide created it, and why medicines cause harm despite passing clinical trials.
Adverse Drug Reactions and Terminology
In this module, you'll learn how adverse drug reactions are classified, the difference between seriousness and severity, and how product labels define expected reactions.
Causality and Case Reporting
In this module, you'll learn to judge whether a drug caused an event, where safety data comes from, and what makes a valid safety case report.
Coding and Global Regulations
In this module, you'll learn how MedDRA coding works, plus the ICH guidelines, quality practices and regulators shaping drug safety worldwide.
Indian Pharmacovigilance, Signals and Careers
In this module, you'll learn how India's drug safety system works, how safety signals lead to label changes, and how to build your career.
Get access to the complete curriculum once you enroll in the course
Frequently Asked Questions
Will I receive a certificate upon completing this free course?
Is this course free?
What will I learn in this Free Pharmacovigilance Course?
You’ll learn the fundamentals of drug safety, including adverse drug reaction classification, seriousness and severity, causality assessment, case validity, safety reporting, MedDRA coding, global regulations, Indian pharmacovigilance, safety signals, and aggregate reporting awareness. The course also explains why pharmacovigilance exists and how safety information influences real decisions about medicines.
Is this free Course suitable for beginners?
Yes, this course is designed for beginners and assumes no prior pharmacovigilance experience. It begins with the meaning and purpose of pharmacovigilance, then introduces ADR terminology, causality, safety cases, coding, regulations, signals, and career opportunities in drug safety.
What topics are covered in Pharmacovigilance free online course with certificate like this one?
The course covers the following modules:
Introduction to Pharmacovigilance
Adverse Drug Reactions and Terminology
Causality and Case Reporting
Coding and Global Regulations
Indian Pharmacovigilance, Signals and Career
What skills will I gain from free pharmacovigilance training?
You’ll gain the following skills:
DR classification
Seriousness assessment
Causality evaluation
Case validity screening
Safety narrative writing
MedDRA coding basics
Regulatory reporting timelines
Indian PV compliance
Signal interpretation
Aggregate report awareness
Does this free course explain adverse drug reactions?
The course explains how adverse drug reactions are classified and how to distinguish seriousness from severity. You’ll also learn how product labeling helps determine whether a reaction is expected, which is an important concept when evaluating drug safety information.
Will this free online pharmacovigilance course teach causality assessment?
Yes, you’ll learn how pharmacovigilance professionals evaluate whether a medicine may have caused an adverse event. The course introduces causality evaluation, safety data sources, and the information needed to make a safety case valid for further assessment and reporting.
Will this free Course teach MedDRA coding?
This course introduces the basics of MedDRA coding and explains why standardized medical terminology is important in pharmacovigilance. You’ll understand how consistent coding helps organize adverse event data, support safety analysis, and improve communication across global drug safety systems.
Does free pharmacovigilance training cover individual case safety reports?
Yes, the course explains where safety information comes from and what makes a valid safety case. You’ll learn the basics of case validity screening and safety narrative writing, helping you understand how adverse event information is documented and prepared for regulatory processes.
What will I learn about safety signals in this pharmacovigilance course online free?
You’ll learn what safety signals are, how they can emerge from accumulated drug safety information, and why they require further evaluation. The course also explains how signal interpretation can contribute to decisions such as updating product information or strengthening safety warnings.
What outcome should I expect after completing this free online course?
By the end, you’ll be able to explain how pharmacovigilance protects patients, classify adverse drug reactions, understand seriousness and causality, recognize valid safety cases, interpret basic MedDRA and regulatory concepts, understand safety signals, and build a strong foundation for further pharmacovigilance training and entry-level drug safety opportunities.